MolNFT v1 · #46469 · protein
Thiazolone-acylsulfonamides as novel HCV NS5B polymerase allosteric inhibitors: convergence of structure-based drug design and X-ray crystallographic study
2O5D: “Thiazolone-acylsulfonamides as novel HCV NS5B polymerase allosteric inhibitors: convergence of…”. X-ray diffraction. MolNFT v1 #46469 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 2O5D
- Type
- protein
- Length
- 1,120 residues
- Chains
- 2
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- UniProt
- P26663
Structure
x-ray diffraction · 2 distinct chains.
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | — | protein | 559 | — | P26663 |
| B | — | protein | 561 | — | P26663 |
Compared structures
- 2O5D · Thiazolone-acylsulfonamides as novel HCV NS5B polymerase allosteric inhibitors… · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P26663
- Elsewhere: RCSB PDB 2O5D · PDBe 2O5D · UniProt P26663
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.